New Insights in the Immunologic Basis of Psoriasis

Kristine E. Nograles, Batya Davidovici, James G. Krueger*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Psoriasis vulgaris is a multifactorial heritable disease characterized by severe inflammation resulting in poorly differentiated, hyperproliferative keratinocytes. Recent advances in genetic analyses have implicated components regulating the interleukin (IL)-23 and nuclear factor-κB pathways as risk factors for psoriasis. These inflammatory pathways exhibit increased activity in skin lesions, and promote secretion of various cytokines, such as IL-17 and IL-22. Unrestrained, the activated inflammatory cytokine network in psoriasis may trigger a vicious cycle of inflammation and cellular proliferation that ultimately results in lesion formation. These advances in genetic analyses, together with the progress made in targeted biological therapy, pave the path to tailor treatment on the basis of an individual's genetic and immunologic profile.

Original languageEnglish
Pages (from-to)3-9
Number of pages7
JournalSeminars in Cutaneous Medicine and Surgery
Issue number1
StatePublished - Mar 2010
Externally publishedYes


FundersFunder number
National Center for Research ResourcesUL1RR024143


    Dive into the research topics of 'New Insights in the Immunologic Basis of Psoriasis'. Together they form a unique fingerprint.

    Cite this